DIALYSIS · CCN 672531
DaVita Grapevine Dialysis
GRAPEVINE, TX 76051
DialysisProfitDaVita
$6.9M
TOTAL REVENUE
25.2%
OPERATING MARGIN
5 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL
Cost report financials (FY2025)
- Net patient revenue
- $6.9M
- Total costs
- $5.2M
- Operating income (rev − costs)
- $1.7M
- Operating margin
- 25.2%
- Total charges
- $6.6M
- Total treatments
- 14,547
- Dialysis stations
- 25
Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.
02 — QUALITY MEASURES
13 quality measures
| Measure | Score | Denominator | Period |
|---|---|---|---|
Standardized ED Visits Within 30 Days of Hospital Discharge DFC_ED30 | 0.84 | 107 | — |
Fistula Rate DFC_FISTULA_RATE | 59.2 | 98 | — |
Five Star Rating DFC_FIVE_STAR | 5 | — | — |
First Year Standardized Kidney Transplant Waitlist Ratio DFC_FYSWR | 2.15 | 49 | — |
Healthcare Worker COVID-19 Vaccination Adherence DFC_HCP_VACC | 2 | — | — |
Patient Hospitalization Rate DFC_HOSPITALIZATION_RATE | 133.3 | 126 | — |
Standard Infection Ratio (SIR) DFC_INFECTION_RATIO | 0.35 | — | — |
Percentage of Adult Patients with Long Term Catheter in Use DFC_LONG_CATHETER | 17 | 98 | — |
Patient Survival (Mortality Rate) DFC_MORTALITY_RATE | 22.3 | 485 | — |
Percentage of Prevalent Patients Waitlisted for Kidney Transplant DFC_PPPW | 34 | 88 | — |
Patient Hospital Readmission Rate DFC_READMISSION_RATE | 17.2 | 83 | — |
Standardized ED Visits Ratio DFC_SEDR | 0.81 | 71 | — |
Patient Transfusion Rate DFC_TRANSFUSION_RATE | 21.1 | 63 | — |